Jan 2018 $138 M Issued in a merger or acquisition $50 to $250 million 9
Cempra Holdings, LLC: Private sale, Jan 2018 × Investors in this round 9 investors had bought by the notice of Jan 19, 2018: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $138 M of $138 M offered
Smallest investment taken no minimum stated
What was sold equity, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Wechsler · Executive Officer, Director · Director, President and Chief Executive Officer Erin T. Duffy · Executive Officer · Executive Vice President and Chief Scientific Officer Paul T. Estrem · Executive Officer · Executive Vice President, Chief Financial Officer and Secretary Sue T. Cammarata · Executive Officer · Executive Vice President and Chief Medical Officer Cecilia J. Gonzalo · Director David J. Gill · Director David P. Zaccardelli · Director Garheng P. Kong · Director Jay J. Galeota, Jr. · Director John H. Johnson · Director Kevin T. Ferro · Director · Chairman of the Board Thomas P. Koestler · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Amount sold includes shares given in consideration for an acquisition of stock of subsidiaries and assets of The Medicines Company.”On a merger: “In connection with the Issuer's acquisition of the capital stock of certain subsidiaries of The Medicines Company and certain assets related to The Medicines Company's infectious disease business.”Signed by Paul Estrem, See Clarification Box in Item # 3. Source: SEC Form D, newest notice filed Jan 19, 2018. Read the notice at the SEC .
equity SEC Nov 2017 $133 M Issued in a merger or acquisition $50 to $250 million 39
Cempra Holdings, LLC: Private sale, Nov 2017 × Investors in this round 39 investors had bought by the notice of Nov 20, 2017: 39 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $133 M of $133 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Daniel Wechsler · Executive Officer, Director · Director, President and Chief Executive Officer Erin P. Duffy · Executive Officer · Executive Vice President and Chief Scientific Officer John P. Temperato · Executive Officer · Executive Vice President and Chief Commercial Officer Paul P. Estrem · Executive Officer · Executive Vice President, Chief Financial Officer and Secretary Sue P. Cammarata · Executive Officer · Executive Vice President and Chief Medical Officer Cecilia Gonzalo · Director David Gill · Director David P. Zaccardelli · Director Garheng P. Kong · Director Jay Galeota · Director John Johnson · Director Kevin P. Ferro · Director Thomas P. Koestler · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “No cash proceeds will be received by the Issuer in connection with the offering. Consideration for Issuer's issued shares is shares of Melinta Subsidiary Corp (f/k/a Melinta Therapeutics, Inc.)”On a merger: “Stock-for-stock merger”Signed by Paul Estrem, See Clarification Box in Item # 3. Source: SEC Form D, newest notice filed Nov 20, 2017. Read the notice at the SEC .
equity SEC Oct 2012 $25 M No. 3 $10 to $50 million 13
Cempra Holdings, LLC: Raise no. 3, Oct 2012 × Investors in this round 13 investors had bought by the notice of Oct 30, 2012: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,507,139
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Mark Hahn · Executive Officer Prabhavathi Fernandes · Executive Officer, Director David Sherill Gill · Director Dov Goldstein · Director Garheng Kong · Director John Johnson · Director P. Sherill Neff · Director Richard Kent · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Jefferies & Company, Inc. (CRD 2347) · broker-dealer Jefferies & Company, Inc. (CRD 2347) · New York, New York Sold in CA, CT, MA, NY, PA Cowen and Company, LLC (CRD 7616) · broker-dealer Cowen and Company, LLC (CRD 7616) · New York, New York Sold in CA, MA, MD, NY Stifel Nicolaus Weisel (CRD 793) · broker-dealer Stifel Nicolaus Weisel (CRD 793) · San Francisco, California Sold in CA, CT, IL, MA, NY, PA, UT, and outside the US Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits in the ordinary course of business no officer, director or promoter will receive any payments from the proceeds of this offering.”Signed by Mark W. Hahn, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 30, 2012. Read the notice at the SEC .
equity SEC Aug 2011 $5 M No. 2 $2 to $10 million 16
Cempra Holdings, LLC: Raise no. 2, Aug 2011 × Investors in this round 16 investors had bought by the notice of Aug 16, 2011: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Mark L. Hahn · Executive Officer Prabhavathi Fernandes · Executive Officer, Director Shane L. Barton · Executive Officer Dov Wistar Goldstein · Director Garheng L. Kong · Director Geeta L. Vemuri · Director I Wistar Morris · Director John L. Johnson · Director Michael L. Corrado · Director Richard Wistar Kent · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits in the ordinary course of business no officer, director or promoter will receive any payments from the proceeds of this offering.”Signed by Prabhavathi Fernandes, Ph.D., President and CEO. Source: SEC Form D, newest notice filed Aug 16, 2011. Read the notice at the SEC .
debt, options SEC May 2009 $46 M No. 1 $10 to $50 million 15
Cempra Holdings, LLC: Raise no. 1, May 2009 × Investors in this round 15 investors had bought by the notice of May 19, 2010: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $46 M of $46 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Limited Liability Company, incorporated in Delaware People named in the notice Prabhavathi Fernandes · Executive Officer, Director Dov Wistar Goldstein · Director Garheng Wistar Kong · Director Geeta Wistar Vemuri · Director I Wistar Morris · Director John H Johnson · Director Michael L Corrado · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits in the ordinary course of business no officer, director or promoter will receive any payments from the proceeds of this offering.”Signed by Prabhavathi Fernandes, Ph.D., President and CEO. Source: SEC Form D and 1 amendment, newest notice filed May 19, 2010. Read the notice at the SEC .
equity SEC